VEGFA and Bartsocas-Papas syndrome 1: In the present study, post-treatment reduced expressions of VEGF were observed both in patients with GRA ≥ 2 and those with GRA < 2; this suggests that PRP has a therapeutic inhibitory effect on aberrant vascular angiogenesis of IC/BPS which is associated with a decrease in urothelial permeability.